Pregnancy outcomes following gestational exposure to papaverine: An observational comparative study.
Itai GuetaAdi BraunAdi GilanMaya BerlinElkana KohnDana BarchelNoa MarkovitsMatitiahu BerkovitchRonen LoebsteinPublished in: British journal of clinical pharmacology (2021)
Short-term gestational exposure to papaverine adjusted for indication was not associated with preterm deliveries, CS, lower birthweight, small for gestational age or perinatal death. Rate of major malformations among 46 first trimester exposures was comparable to controls.